intelligent omics limited

3.5

intelligent omics limited Company Information

Share INTELLIGENT OMICS LIMITED
Live 
EstablishedMicroHigh

Company Number

06500709

Registered Address

biocity nottingham, pennyfoot street, nottingham, NG1 1GF

Industry

Research and experimental development on biotechnology

 

Telephone

03333231843

Next Accounts Due

September 2025

Group Structure

View All

Directors

Graham Ball15 Years

Simon Haworth12 Years

View All

Shareholders

nottingham trent university 49.1%

robert rees 13.7%

View All

intelligent omics limited Estimated Valuation

£333.4k

Pomanda estimates the enterprise value of INTELLIGENT OMICS LIMITED at £333.4k based on a Turnover of £261k and 1.28x industry multiple (adjusted for size and gross margin).

intelligent omics limited Estimated Valuation

£695.9k

Pomanda estimates the enterprise value of INTELLIGENT OMICS LIMITED at £695.9k based on an EBITDA of £133.2k and a 5.22x industry multiple (adjusted for size and gross margin).

intelligent omics limited Estimated Valuation

£444.6k

Pomanda estimates the enterprise value of INTELLIGENT OMICS LIMITED at £444.6k based on Net Assets of £208.4k and 2.13x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Intelligent Omics Limited Overview

Intelligent Omics Limited is a live company located in nottingham, NG1 1GF with a Companies House number of 06500709. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in February 2008, it's largest shareholder is nottingham trent university with a 49.1% stake. Intelligent Omics Limited is a established, micro sized company, Pomanda has estimated its turnover at £261k with high growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Intelligent Omics Limited Health Check

Pomanda's financial health check has awarded Intelligent Omics Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating3.5out of 5
positive_score

4 Strong

positive_score

2 Regular

positive_score

5 Weak

size

Size

annual sales of £261k, make it smaller than the average company (£4.2m)

£261k - Intelligent Omics Limited

£4.2m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 27%, show it is growing at a faster rate (14.3%)

27% - Intelligent Omics Limited

14.3% - Industry AVG

production

Production

with a gross margin of 55%, this company has a comparable cost of product (55%)

55% - Intelligent Omics Limited

55% - Industry AVG

profitability

Profitability

an operating margin of 50.6% make it more profitable than the average company (-5.5%)

50.6% - Intelligent Omics Limited

-5.5% - Industry AVG

employees

Employees

with 3 employees, this is below the industry average (53)

3 - Intelligent Omics Limited

53 - Industry AVG

paystructure

Pay Structure

on an average salary of £82.9k, the company has an equivalent pay structure (£82.9k)

£82.9k - Intelligent Omics Limited

£82.9k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £87k, this is less efficient (£131.9k)

£87k - Intelligent Omics Limited

£131.9k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 1 days, this is earlier than average (53 days)

1 days - Intelligent Omics Limited

53 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 508 days, this is slower than average (62 days)

508 days - Intelligent Omics Limited

62 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Intelligent Omics Limited

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 2 weeks, this is less cash available to meet short term requirements (32 weeks)

2 weeks - Intelligent Omics Limited

32 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 86.6%, this is a higher level of debt than the average (52.2%)

86.6% - Intelligent Omics Limited

52.2% - Industry AVG

INTELLIGENT OMICS LIMITED financials

EXPORTms excel logo

Intelligent Omics Limited's latest turnover from December 2023 is estimated at £261 thousand and the company has net assets of £208.4 thousand. According to their latest financial statements, Intelligent Omics Limited has 3 employees and maintains cash reserves of £18 thousand as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Feb 2010
Turnover260,968362,412245,408128,58069,239189,440375,16312,56904,997,4041,475,7441,807,020173,210110,29121,668
Other Income Or Grants000000000000000
Cost Of Sales117,465166,652119,61461,24434,15791,292186,6966,54902,574,595793,093971,17287,20951,7349,113
Gross Profit143,503195,761125,79567,33535,08298,148188,4676,02002,422,809682,651835,84886,00058,55712,555
Admin Expenses11,429103,70818,50831,41369,572189,64041,84747,977-22,0152,522,328671,582672,148159,54796,09531,037
Operating Profit132,07492,053107,28735,922-34,490-91,492146,620-41,95722,015-99,51911,069163,700-73,547-37,538-18,482
Interest Payable9531,10587445300000007,17213,6726,5000
Interest Receivable5462,112211273747502662647275350168440351273
Pre-Tax Profit131,66793,060106,62335,496-34,116-90,742146,886-41,93122,063-99,24411,419156,696-86,779-43,687-18,209
Tax-32,917-17,681-20,258-6,74400-27,9080-4,4120-2,626-37,607000
Profit After Tax98,75075,37986,36528,752-34,116-90,742118,978-41,93117,650-99,2448,793119,089-86,779-43,687-18,209
Dividends Paid000000000000000
Retained Profit98,75075,37986,36528,752-34,116-90,742118,978-41,93117,650-99,2448,793119,089-86,779-43,687-18,209
Employee Costs248,829233,156155,05770,39268,28967,699243,36657,60203,060,900798,8651,065,512159,915103,61752,370
Number Of Employees332111410541520321
EBITDA*133,22794,179109,83040,424-28,135-89,971146,695-41,95722,804-97,25012,550163,700-73,547-37,538-18,482

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Feb 2010
Tangible Assets1,1532,3063,7134,5016,3551,44675007891,48108511,564818
Intangible Assets1,475,1711,195,421864,232664,031708,252623,002569,7225,070,6265,070,6263,909,9232,251,8951,185,010143,52068,03111,356
Investments & Other000000000349349449000
Debtors (Due After 1 year)000000000000000
Total Fixed Assets1,476,3241,197,727867,945668,532714,607624,448569,7975,070,6265,070,6263,911,0612,253,7251,185,459144,37169,59512,174
Stock & work in progress000000000000000
Trade Debtors1,28753,68458,10016,0002,70049,99683,3149000193,278175,749168,76122,71618,4752,525
Group Debtors000000000000000
Misc Debtors57,26695,54749,28625,23440,19527,129105,0301,819,758137,206000000
Cash18,0403,794116,90551,5022,52697,311102,6743,70016,9191,961108,21031,83035,415140,495109,263
misc current assets00000000019,13600000
total current assets76,593153,025224,29192,73645,421174,436291,0181,824,358154,125214,375283,959200,59158,131158,970111,788
total assets1,552,9171,350,7521,092,236761,268760,028798,884860,8156,894,9845,224,7514,125,4362,537,6841,386,050202,502228,565123,962
Bank overdraft3,0063,0061,7321,73200000000000
Bank loan000000000000000
Trade Creditors 163,546104,8202,13474,015020,4875,0437,88002,662,857435,937748,61961,29721,25316,171
Group/Directors Accounts000000000000000
other short term finances000000000000000
hp & lease commitments000000000000000
other current liabilities202,42098,48645,549424,171840,842825,095811,7284,244,1953,184,615000000
total current liabilities368,972206,31249,415499,918840,842845,582816,7714,252,0753,184,6152,662,857435,937748,61961,29721,25316,171
loans4,1717,14111,38413,11600000000220,671199,9990
hp & lease commitments000000000000000
Accruals and Deferred Income00167,72200000068,7111,127,82321,986000
other liabilities971,3411,027,616829,411300,2960002,718,0182,073,3131,444,695925,507575,82200125,000
provisions000000000000000
total long term liabilities975,5121,034,7571,008,517313,4120002,718,0182,073,3131,513,4062,053,330597,808220,671199,999125,000
total liabilities1,344,4841,241,0691,057,932813,330840,842845,582816,7716,970,0935,257,9284,176,2632,489,2671,346,427281,968221,252141,171
net assets208,433109,68334,304-52,062-80,814-46,69844,044-75,109-33,177-50,82748,41739,623-79,4667,313-17,209
total shareholders funds208,433109,68334,304-52,062-80,814-46,69844,044-75,109-33,177-50,82748,41739,623-79,4667,313-17,209
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Feb 2010
Operating Activities
Operating Profit132,07492,053107,28735,922-34,490-91,492146,620-41,95722,015-99,51911,069163,700-73,547-37,538-18,482
Depreciation1,1532,1262,5434,5026,3551,5217507892,2691,4810000
Amortisation000000000000000
Tax-32,917-17,681-20,258-6,74400-27,9080-4,4120-2,626-37,607000
Stock000000000000000
Debtors-90,67841,84566,152-1,661-34,230-111,219-1,632,3141,683,452-56,07217,5296,988146,0454,24118,4752,525
Creditors58,726102,686-71,88174,015-20,48715,444-2,8377,880-2,662,8572,226,920-312,682687,32240,04421,25316,171
Accruals and Deferred Income103,934-114,785-210,900-416,67115,74713,367-3,432,4671,059,5803,115,904-1,059,1121,105,83721,986000
Deferred Taxes & Provisions000000000000000
Cash flow from operations353,64822,554-259,361-307,3151,35550,059-1,684,203-657,949527,5111,053,029796,091689,356-37,744-34,760-4,836
Investing Activities
capital expenditure-279,750-331,908-201,95641,573-96,514-56,1724,500,7540-1,160,703-1,659,605-1,069,847-1,040,639-74,776-69,595-12,174
Change in Investments00000000-3490-100449000
cash flow from investments-279,750-331,908-201,95641,573-96,514-56,1724,500,7540-1,160,354-1,659,605-1,069,747-1,041,088-74,776-69,595-12,174
Financing Activities
Bank loans000000000000000
Group/Directors Accounts000000000000000
Other Short Term Loans 000000000000000
Long term loans-2,970-4,243-1,73213,1160000000-220,67120,672199,9990
Hire Purchase and Lease Commitments000000000000000
other long term liabilities-56,275198,205529,115300,29600-2,718,018644,705628,618519,188349,685575,82200125,000
share issue001000175-10010051,0001,000
interest-4071,007-663-4263747502662647275350-7,004-13,232-6,149273
cash flow from financing-59,652194,969526,721312,986374750-2,717,577644,730628,665519,463350,036348,1477,440244,850126,273
cash and cash equivalents
cash14,246-113,11165,40348,976-94,785-5,36398,974-13,21914,958-106,24976,380-3,585-105,080140,495109,263
overdraft01,27401,73200000000000
change in cash14,246-114,38565,40347,244-94,785-5,36398,974-13,21914,958-106,24976,380-3,585-105,080140,495109,263

intelligent omics limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for intelligent omics limited. Get real-time insights into intelligent omics limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Intelligent Omics Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for intelligent omics limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in NG1 area or any other competitors across 12 key performance metrics.

intelligent omics limited Ownership

INTELLIGENT OMICS LIMITED group structure

Intelligent Omics Limited has no subsidiary companies.

Ultimate parent company

INTELLIGENT OMICS LIMITED

06500709

INTELLIGENT OMICS LIMITED Shareholders

nottingham trent university 49.06%
robert rees 13.71%
graham ball 13.71%
simon haworth 13.71%
andrew sutton 7.84%
mobius fund 1.96%

intelligent omics limited directors

Intelligent Omics Limited currently has 4 directors. The longest serving directors include Professor Graham Ball (Aug 2009) and Dr Simon Haworth (Mar 2012).

officercountryagestartendrole
Professor Graham Ball54 years Aug 2009- Director
Dr Simon HaworthUnited Kingdom63 years Mar 2012- Director
Dr William MasonUk73 years Aug 2018- Director
Mr Robert GrundyNorthern Ireland49 years May 2023- Director

P&L

December 2023

turnover

261k

-28%

operating profit

132.1k

0%

gross margin

55%

+1.8%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

208.4k

+0.9%

total assets

1.6m

+0.15%

cash

18k

+3.75%

net assets

Total assets minus all liabilities

intelligent omics limited company details

company number

06500709

Type

Private limited with Share Capital

industry

72110 - Research and experimental development on biotechnology

incorporation date

February 2008

age

16

incorporated

UK

ultimate parent company

None

accounts

Total Exemption Full

last accounts submitted

December 2023

previous names

intelligent omics limited (March 2019)

compandx limited (March 2019)

accountant

-

auditor

-

address

biocity nottingham, pennyfoot street, nottingham, NG1 1GF

Bank

-

Legal Advisor

-

intelligent omics limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 1 charges/mortgages relating to intelligent omics limited. Currently there are 1 open charges and 0 have been satisfied in the past.

charges

intelligent omics limited Companies House Filings - See Documents

datedescriptionview/download